HDAC2 attenuates TRAIL-induced apoptosis of pancreatic cancer cells

BACKGROUND: Pancreatic ductal adenocarcinoma (PDAC) is one of the most malignant tumors with a dismal prognosis and no effective conservative therapeutic strategies. Although it is demonstrated that histone deacetylases (HDACs), especially the class I HDACs HDAC1, 2 and 3 are highly expressed in thi...

Descripción completa

Detalles Bibliográficos
Autores principales: Schüler, Susanne, Fritsche, Petra, Diersch, Sandra, Arlt, Alexander, Schmid, Roland M, Saur, Dieter, Schneider, Günter
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2010
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2867820/
https://www.ncbi.nlm.nih.gov/pubmed/20398369
http://dx.doi.org/10.1186/1476-4598-9-80

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2867820/
https://www.ncbi.nlm.nih.gov/pubmed/20398369
http://dx.doi.org/10.1186/1476-4598-9-80

Ejemplares similares